Valneva SE - ADR

Business: Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs.

IPO Date: 05-May-2021

Chairman of the Management Board, Pres & CEO: Mr. Thomas Lingelbach

Director Gen., Chief Bus. Officer & Member of Management Board: Mr. Franck Grimaud MBA

Listing: NASDAQ: VALN

Country: France

Headquarters: Saint-Herblain,

Website: https://valneva.com

Market cap: $1,288.66 Mln

Revenue (TTM): €24.29 Mln

Earnings (TTM): €-71.76 Mln

Cash: €0.00 Mln

Total Debt: €0.00 Mln

Insider's Holding: 0.00%

Liquidity: Low

52 Week range: $13.71 - 67.84

Shares outstanding: 53,828,600

10 Years Aggregate:

• CFO: €182.41 Mln
• EBITDA: €-96.26 Mln
• Net Profit: €-282.80 Mln